Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

TNYA

Tenaya Therapeutics (TNYA)

Tenaya Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:TNYA
DateHeureSourceTitreSymboleSociété
14/05/202422h15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TNYATenaya Therapeutics Inc
14/05/202422h09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNYATenaya Therapeutics Inc
14/05/202422h05GlobeNewswire Inc.Tenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:TNYATenaya Therapeutics Inc
02/05/202423h00GlobeNewswire Inc.Tenaya Therapeutics to Highlight Growing Capabilities in Capsid Engineering, Gene Editing and Manufacturing at the American Society of Gene and Cell Therapy 27th Annual MeetingNASDAQ:TNYATenaya Therapeutics Inc
18/03/202421h05GlobeNewswire Inc.Tenaya Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:TNYATenaya Therapeutics Inc
18/03/202413h30GlobeNewswire Inc.Tenaya Therapeutics Announces Publication of TN-401 Gene Therapy Preclinical Data in Nature Communications MedicineNASDAQ:TNYATenaya Therapeutics Inc
28/02/202401h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNYATenaya Therapeutics Inc
27/02/202422h30GlobeNewswire Inc.Tenaya Therapeutics to Participate in Upcoming March Investor ConferencesNASDAQ:TNYATenaya Therapeutics Inc
26/02/202414h30GlobeNewswire Inc.Tenaya Therapeutics Announces Publication of Preclinical HDAC6 Inhibitor Data for Heart Failure with Preserved Ejection Fraction in Nature CommunicationsNASDAQ:TNYATenaya Therapeutics Inc
17/02/202402h13Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TNYATenaya Therapeutics Inc
08/02/202423h25Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TNYATenaya Therapeutics Inc
08/02/202414h00GlobeNewswire Inc.Tenaya Therapeutics Announces Pricing of Underwritten OfferingNASDAQ:TNYATenaya Therapeutics Inc
31/01/202422h11Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TNYATenaya Therapeutics Inc
03/01/202414h30GlobeNewswire Inc.Tenaya Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:TNYATenaya Therapeutics Inc
21/11/202322h30GlobeNewswire Inc.Tenaya Therapeutics to Participate at the 35th Annual Piper Sandler Healthcare ConferenceNASDAQ:TNYATenaya Therapeutics Inc
08/11/202322h05GlobeNewswire Inc.Tenaya Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:TNYATenaya Therapeutics Inc
26/10/202314h30GlobeNewswire Inc.Tenaya Therapeutics Announces FDA Clearance to Begin Clinical Testing of TN-401 Gene Therapy for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular CardiomyopathyNASDAQ:TNYATenaya Therapeutics Inc
09/10/202314h30GlobeNewswire Inc.Tenaya Therapeutics Presents Encouraging New Clinical and Preclinical Data from HDAC6 Inhibitor Program TN-301 for the Potential Treatment of Heart Failure with Preserved Ejection Fraction at the 2023 HFSA Annual Scientific MeetingNASDAQ:TNYATenaya Therapeutics Inc
05/10/202314h30GlobeNewswire Inc.Tenaya Therapeutics Doses First Patient in the MyPeak-1™ Phase 1b Clinical Trial of TN-201 for the Treatment of MYBPC3-Associated Hypertrophic CardiomyopathyNASDAQ:TNYATenaya Therapeutics Inc
02/10/202323h30GlobeNewswire Inc.Tenaya Therapeutics Publishes Preclinical Data in Circulation Highlighting the Clinical Potential of Cellular Reprogramming for Cardiac RegenerationNASDAQ:TNYATenaya Therapeutics Inc
21/09/202322h05GlobeNewswire Inc.Tenaya Therapeutics to Present Data for TN-301 and TN-201 at Upcoming Medical ConferencesNASDAQ:TNYATenaya Therapeutics Inc
31/08/202322h05GlobeNewswire Inc.Tenaya Therapeutics to Participate at the 21st Annual Morgan Stanley Global Healthcare ConferenceNASDAQ:TNYATenaya Therapeutics Inc
09/08/202322h05GlobeNewswire Inc.Tenaya Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:TNYATenaya Therapeutics Inc
02/08/202322h05GlobeNewswire Inc.Tenaya Therapeutics to Participate at the 43rd Annual Canaccord Genuity Growth ConferenceNASDAQ:TNYATenaya Therapeutics Inc
10/05/202322h36Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TNYATenaya Therapeutics Inc
10/05/202322h29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TNYATenaya Therapeutics Inc
10/05/202322h19GlobeNewswire Inc.Tenaya Therapeutics Reports First Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:TNYATenaya Therapeutics Inc
03/05/202314h00GlobeNewswire Inc.Tenaya Highlights Growing Capabilities in AAV Manufacturing, Capsid Engineering and Expansion into Gene Editing with Six Abstracts Accepted for Presentation at the ASGCT 26th Annual MeetingNASDAQ:TNYATenaya Therapeutics Inc
02/05/202314h43Dow Jones NewsTenaya Therapeutics Gets FDA Fast-Track Designation for TN-201NASDAQ:TNYATenaya Therapeutics Inc
02/05/202313h50GlobeNewswire Inc.Tenaya Therapeutics Receives FDA Fast Track Designation for TN-201NASDAQ:TNYATenaya Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:TNYA